Literature DB >> 26685675

Characterisation of the genes involved in the biosynthesis and attachment of the aminodeoxysugar D-forosamine in the auricin gene cluster of Streptomyces aureofaciens CCM3239.

Carmen Bekeova1, Alena Rehakova1, Lubomira Feckova1, Silvia Vlckova2, Renata Novakova1, Erik Mingyar1, Jan Kormanec3.   

Abstract

We previously identified the aur1 gene cluster which produces the angucycline antibiotic auricin. Preliminary characterisation of auricin revealed that it is modified by a single aminodeoxysugar, D-forosamine. Here we characterise the D-forosamine-specific genes. The four close tandem genes, aur1TQSV, encoding enzymes involved in the initial steps of the deoxysugar biosynthesis, were located on a large operon with other core auricin biosynthetic genes. Deleting these genes resulted in the absence of auricin and the production of deglycosylated auricin intermediates. The two final D-forosamine biosynthetic genes, sa59, an NDP-hexose aminotransferase, and sa52, an NDP-aminohexose N-dimethyltransferase, are located in a region rather distant from the core auricin genes. A deletion analysis of these genes confirmed their role in D-forosamine biosynthesis. The Δsa59 mutant had a phenotype similar to that of the cluster deletion mutant, while the Δsa52 mutant produced an auricin with a demethylated D-forosamine. Although auricin contains a single deoxyhexose, two glycosyltransferase genes were found to participate in the attachment of D-forosamine to the auricin aglycon. An analysis of the expression of the D-forosamine biosynthesis genes revealed that the initial D-forosamine biosynthetic genes aur1TQSV are regulated together with the other auricin core genes by the aur1Ap promoter under the control of the auricin-specific activator Aur1P. The expression of the other D-forosamine genes, however, is governed by promoters differentially dependent upon the two SARP family auricin-specific activators Aur1PR3 and Aur1PR4. These promoters contain direct repeats similar to the SARP consensus sequence and are involved in the interaction with both regulators.

Entities:  

Keywords:  Antibiotics; Auricin; D-Forosamine; Polyketide; Regulation; Secondary metabolite; Streptomyces

Mesh:

Substances:

Year:  2015        PMID: 26685675     DOI: 10.1007/s00253-015-7214-9

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  4 in total

1.  A stable vector for efficient production of heterologous proteins and secondary metabolites in streptomycetes.

Authors:  Renata Novakova; Dagmar Homerova; Dominika Csolleiova; Bronislava Rezuchova; Beatrica Sevcikova; Rachel Javorova; Lubomira Feckova; Jan Kormanec
Journal:  Appl Microbiol Biotechnol       Date:  2022-09-29       Impact factor: 5.560

2.  A Structural Analysis of the Angucycline-Like Antibiotic Auricin from Streptomyces lavendulae Subsp. Lavendulae CCM 3239 Revealed Its High Similarity to Griseusins.

Authors:  Maria Matulova; Lubomira Feckova; Renata Novakova; Erik Mingyar; Dominika Csolleiova; Martina Zduriencikova; Jan Sedlak; Vladimir Patoprsty; Vlasta Sasinkova; Iveta Uhliarikova; Beatrica Sevcikova; Bronislava Rezuchova; Dagmar Homerova; Jan Kormanec
Journal:  Antibiotics (Basel)       Date:  2019-07-25

3.  Activation and Identification of a Griseusin Cluster in Streptomyces sp. CA-256286 by Employing Transcriptional Regulators and Multi-Omics Methods.

Authors:  Charlotte Beck; Tetiana Gren; Francisco Javier Ortiz-López; Tue Sparholt Jørgensen; Daniel Carretero-Molina; Jesús Martín Serrano; José R Tormo; Daniel Oves-Costales; Eftychia E Kontou; Omkar S Mohite; Erik Mingyar; Evi Stegmann; Olga Genilloud; Tilmann Weber
Journal:  Molecules       Date:  2021-10-30       Impact factor: 4.411

4.  A New Family of Transcriptional Regulators Activating Biosynthetic Gene Clusters for Secondary Metabolites.

Authors:  Renata Novakova; Erik Mingyar; Lubomira Feckova; Dagmar Homerova; Dominika Csolleiova; Bronislava Rezuchova; Beatrica Sevcikova; Rachel Javorova; Jan Kormanec
Journal:  Int J Mol Sci       Date:  2022-02-23       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.